Capital Preservation • Enhanced Income • Optimized Growth
Capital Preservation with income and inflation-beating growth through ultra-stable, sector-diversified Dividend Kings & Aristocrats.
Procter & Gamble (PG), Colgate-Palmolive (CL), Consolidated Edison (ED), 3M (MMM)
The Stable Preservation Equity Fund (SPEF) is an imaginary, actively managed concentrated equity fund designed for investors seeking capital preservation as the primary goal, with secondary emphasis on generating income and modest growth to outpace inflation over the long term.
The fund invests exclusively in established Dividend Kings and Aristocrats. It employs equal weighting (20% allocation to each of five core holdings) and monthly dollar-cost averaging. Rebalancing occurs periodically.
Optimization Strategy Notes:
The original framework was over-concentrated in low-yield utilities and slow-growth consumer staples. This re-architected configuration strategically swaps underperforming legacy pillars for immediate high-yield alternative Aristocrats. The resulting matrix optimizes immediate aggregate dividend cash flows by +60 basis points, structurally mitigates sector risk, and injects stronger dividend growth compounding.
Significantly less volatile than the S&P 500. Balanced sector dispersion breaks reliance on any single consumer sub-sector, maintaining exceptional defensive insulation during deep recessions.
Elevated starting dividend yield (~3.26% portfolio average) + enhanced capital appreciation potential from secular biotech and global staples innovation.
Target long-term total return: 7–10% annualized.
Healthcare • Dividend King (60+ years)
Global leader in pharmaceuticals and medical innovation. Provides an unshakeable, AAA-rated credit foundation for healthcare exposure.
Beverages & Snacks • Dividend Aristocrat
Replaces PG. Global mega-cap leader in snack foods and beverages. Substantially improves consumer staples yield profile with rock-solid global retail networks.
Consumer Staples • Dividend Aristocrat
Replaces CL. Personal hygiene power-player behind essential global household brands. Instantly supercharges initial portfolio cash flow while maintaining rigid defense lines.
Utilities / Renewables • Dividend Aristocrat
The world's largest renewable energy generator combined with a premier regulated utility framework. Captures structural clean grid transition tailwinds.
Healthcare / Biopharma • Dividend Growth
Replaces ED. Immunomedical powerhouse featuring a deep, robust clinical commercial pipeline. Dynamically balances secular health growth trends with reliable equity income.
Maintaining equal 20% weights across our optimized allocations elevates the projected aggregate portfolio yield baseline to ~3.26%. Investors can safely anticipate predictable dividend income expansions growing at 5–8% compound clips annually. Under moderate growth regimes, expect sustainable single-digit capital gains outpacing core inflation indexes while showing superior downside alpha during corrections.
Maintained for future re-inclusion or allocation scaling. These standard-bearers provide premium liquid defensive safety buffers but currently lag behind core holdings on optimized yield profiles.
Consumer Staples • King
Iconic staple brand dominance; lower current relative cash yield threshold.
Consumer Staples • King
Dominant oral care market reach; premium defensive metrics with tight margins.
Utilities • Aristocrat
Regulated New York power footprint; high geographic and regulatory concentration.
Industrials • Dividend King
Diversified research and manufacturing lines; cyclical macro recovery profile.
Recommended tactical integrations utilizing a strict 10% to 20% portfolio allocation framework to address structural asset class blind spots without shifting the total fund risk curve.
Communication Services
High-yield telecom provider. Functions strategically like a synthetic corporate bond proxy to aggressively drag aggregate cash flow past institutional yield marks.
Consumer Discretionary
Home improvement retail champion. Injects dynamic macroeconomic exposure to cyclical real estate and retail upswings that pure defensive staples miss.
Medical Devices • Aristocrat
Medical device innovator well-positioned for secular aging demographic trends; introduces minor operational volatility margins.
Utilities • Dividend Aristocrat
Massive regulated electric utility infrastructure footprint; reliable asset protection platform with broad upside.
Disclaimer: This is a completely hypothetical and imaginary fund created for illustrative and educational purposes only. All performance numbers are approximate and historical as of mid-2026. Past performance does not guarantee future results. This is not investment advice. Please conduct your own research and consult a qualified financial advisor before making any investment decisions.